Administration is responsible for the organizational support and fiscal oversight of all Case Comprehensive Cancer Center (Case CCC) activities based at Case Western Reserve University (CWRU) and its affiliated institutions. University Hospitals (UH) and Cleveland Clinic (CCF). As the center of operations for the Cancer Center, Administration is responsible for communicating regularly with members to disseminate opportunities for funding and scientific interactions, maintaining an integrated calendar of activities and providing a support service to implement retreats, meetings, and conferences, facilitating and managing multi-investigator grants, providing administrative support to the shared resources, and supporting post-doctoral training. A staff of 12 under the leadership of Anne Duli, MPA, Associate Director for Research Administration and Finance, directly manages over $15 million in annual cancer research support. Regular administrative meetings with UH and CCF administrators promote organizational integration for cancer research across the affiliated institutions. Topics for this group's meetings include flow of information across the consortium, developments and priorities for the Cancer Center, funding opportunities, grant oversight and reporting, clinical research topics, and improved processes for communication, funds transfer and reporting. Accomplishments for Administration include providing support for the reorganization and realignment of the scientific programs, for major initiatives such as strategic planning, developing a review process for tissue use, facilitating the applications for 7 new and renewal multidisciplinary projects, training grant renewals, over 10 applications for ARRA funding, and the successful recruitment of 8 new cancer research faculty, with 3 of them having primary appointments in the Cancer Center. Future plans include providing support for key scientific initiatives of the Cancer Center, the development of the Office of Cancer Health Disparities, partnering with the Clinical and Translational Research Collaborative to establish complementary resources, streamlining administrative inter-institutional transactions and strengthening internal management of financial information.
The Case Comprehensive Cancer Center is Northeast Ohio's only NCI designated comprehensive cancer center providing bench-to-bedside medical research involving partnerships between basic, clinical and population scientists to speed translation of laboratory discoveries into new prevention/intervention and cancer treatments.
|Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182|
|Burger, Denis R; Parker, Yvonne; Guinta, Kathryn et al. (2018) PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice. Biol Blood Marrow Transplant 24:260-266|
|Shi, Xiaojun; Wang, Bingcheng (2018) Caught in the ""Akt"": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF. Sci Signal 11:|
|Tartakoff, Alan Michael; Dulce, David; Landis, Elizabeth (2018) Delayed Encounter of Parental Genomes Can Lead to Aneuploidy in Saccharomyces cerevisiae. Genetics 208:139-151|
|Gromovsky, Anthony D; Schugar, Rebecca C; Brown, Amanda L et al. (2018) ?-5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators. Arterioscler Thromb Vasc Biol 38:218-231|
|Ignatz-Hoover, James J; Wang, Victoria; Mackowski, Nathan M et al. (2018) Aberrant GSK3? nuclear localization promotes AML growth and drug resistance. Blood Adv 2:2890-2903|
|Hubler, Zita; Allimuthu, Dharmaraja; Bederman, Ilya et al. (2018) Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature 560:372-376|
|Asthana, Abhishek; Ramakrishnan, Parameswaran; Vicioso, Yorleny et al. (2018) Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death. Mol Cancer Ther 17:2226-2237|
|Belur Nagaraj, Anil; Kovalenko, Olga; Avelar, Rita et al. (2018) Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer. Clin Cancer Res 24:4588-4601|
|Yang, Xiaosong; Pan, You; Qiu, Zhaojun et al. (2018) RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells. Clin Cancer Res 24:1629-1643|
Showing the most recent 10 out of 1227 publications